STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets tough blood cancers
Disease control CompletedThis study tested whether combining two drugs could help control chronic lymphocytic leukemia and related blood cancers. It included 41 adults whose cancer had returned after previous treatment or who hadn't yet received treatment. Researchers gave patients an antibody drug that …
Matched conditions: STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Drug trial aims to wipe out lingering cancer cells in leukemia patients
Disease control CompletedThis study tested whether taking the drug ibrutinib as a long-term maintenance treatment could eliminate tiny, hard-to-detect amounts of cancer that remain after initial therapy for chronic lymphocytic leukemia (CLL). It involved 35 patients who had responded to their first treat…
Matched conditions: STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC